Safety and Efficacy of Allogeneic Mesenchymal Stem Cells in Patients With Rapidly Progressive Interstitial Lung Disease

Conditions

• Idiopathic Interstitial Pneumonia
• Interstitial Lung Disease
• Idiopathic Pulmonary Fibrosis

Interventions

• DRUG: Bone marrow mesenchymal stem cells
• DRUG: Placebo

Sponsor

Federal Research Clinical Center of Federal Medical & Biological Agency, Russia